Search Constraints
Search Results
Select an image to start the slideshow
Physical Activity May be a Modifiable Risk Factor for Cognitive Decline in African Americans and Caucasians at High Risk for Developing Alzheimer's Disease
1 of 18
Amplification of amyloid-beta strains and their connection to tau in Alzheimer’s Disease
2 of 18
RNA-binding proteins with mixed charge domains self-assemble, aggregate, and interact with core pathologies in Alzheimer's Disease
3 of 18
Genome-wide alteration of 5-hydroxymethylcytosine in a mouse model of Alzheimer's disease
4 of 18
M1 Muscarinic Acetylcholine Receptor Signaling and Regulation ofAmyloid Precursor Protein Processing
5 of 18
Aberrant Proteasome Pathway in Alzheimer's Disease at Early
Stage revealed by Whole-Transcriptome Study
6 of 18
Characterization of the Relationship Between LR11 and Tau Pathology
7 of 18
Identification and characterization of disease-associated proteins
in frontotemporal lobar degeneration
8 of 18
APOE ε4, but not diabetes, is a risk factor for
Alzheimer's Disease
9 of 18
Characterization of LR11/SorLA in Mild Cognitive Impairment
10 of 18
Association between Anti-Inflammatory Interleukin-10 and Executive Function in African American Women at risk for Alzheimer's Disease
11 of 18
Neuron-specific cellular functions of Interleukin-9 in Alzheimer’s Disease
12 of 18
From epigenetic memory to memory loss: How tau prevents LSD1 from regulating transcription and induces cell death in Alzheimer’s disease
13 of 18
Amyloid Precursor Protein Regulation by G Protein-Coupled Receptor 12
14 of 18
Development of Region-Specific Tau Pathology in P301S Mice
15 of 18
LCMT-1 is an essential component of neuronal development
16 of 18
Alzheimer's Disease Associated Genomic Variants Identified in White Populations are Present in African Americans at Risk for Alzheimer's Disease Due to Family History
17 of 18
The Association of Alzheimer’s Disease-related Blood-based Biomarkers with Cognitive Test Performance in the Congolese Population
18 of 18